-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

201. Granulocytes, Monocytes, and Macrophages: Poster III

Symposia: Granulocytes, Monocytes, and Macrophages Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Gobind S Chugh, BS1*, Vahagn Makaryan, MD2, Merideth Kelley, MS1* and David C. Dale, MD1

1University of Washington, Seattle, WA
2Department of Medicine, University of Washington, Seattle, WA

Yvonne Veltman1*, Anton Langerak2*, Berna Beverloo, PhD3*, Roel Fiets4*, Henk-Jan Boiten, MD, PhD, MSc5* and Pim Mutsaers, MD6*

1Erasmus University Medical Center, Rotterdam, Netherlands
2Erasmus MC, Rotterdam, NLD
3Erasmus MC, University Medical Center Rotterdam, Department of Clinical Genetics, Rotterdam, Netherlands
4Amphia Hospital, Breda, NLD
5Department of Hematology, Sint Franciscus Gasthuis, Rotterdam, NLD
6Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands

Nao Takasugi1*, Ryota Shirai, MD, PhD2*, Tomoo Osumi, MD3*, Kenichi Sakamoto, MD, PhD4*, Ko Kudo, MD, PhD5*, Mariko Tanaka, MD, PhD6*, Toru Uchiyama, MD, PhD7*, Daisuke Tomizawa, MD, PhD8, Tetsuo Ushiku, MD, PhD6*, Takako Yoshioka, MD, PhD9*, Yoko Shioda, MD, PhD8* and Motohiro Kato, MD, PhD1

1Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
2Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan
3Children’s Cancer Center, National Center For Child Health and Development, Tokyo, Japan
4Department of Pediatrics, Shinshu University of Medical Science, Nagano, Japan
5Department of Pediatrics, Hirosaki University, Graduate School of Medicine, Aomori, Japan
6Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
7Department of Human Genetics, National Research Institute for Child Health and Development, Tokyo, Japan
8Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
9Department of Pathology, National Center for Child Health and Development, Tokyo, Japan

Linda Beneforti1,2*, Paul Milne3*, Aurora Chinnici1,2*, Maria Luisa Coniglio1*, Sébastien Héritier4*, Astrid Van Halteren5,6*, Caroline Hutter7*, Irene Trambusti1*, Francesco Pegoraro8,9*, Zofia Hélias-Rodzewicz4*, Raphaela Schwentner7*, Natasja Roozeboom10*, Michele Tanturli11*, Jean-Francois Emile12*, Cor Van Den Bos6*, Milen Minkov7*, Jean Donadieu4, Matthew Collin, MD, PhD3 and Elena Sieni, MD13*

1Pediatric Hematology Oncology, Meyer Children’s Hospital IRCCS, Florence, Italy
2Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy
3Newcastle University Translational and Clinical Research Institute, Newcastle Upon Tyne, United Kingdom
4French Reference Center for Histiocytosis, Department of Pediatric Hematology and Oncology, Trousseau Hospital, AP-HP, Sorbonne Université, Paris, France
5Erasmus University Medical Center, Rotterdam, Netherlands
6Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
7LCH Study group, CCRI, St. Anna Kinderkrebsforschung, Vienna, Austria
8Department of Health Sciences, University of Florence, Florence, Italy
9Department of Hematology and Oncology, Meyer Children’s Hospital IRCCS, Florence, Italy
10Sanquin, Amsterdam, Netherlands
11Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
12Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Versailles, France
13Meyer Children's Hospital, Florence, Italy

Oussama Abla1, Jennifer Picarsic2*, Jean-Francois Emile3,4*, Laura Galluzzo5*, Arnelle Lardizabal6*, Faten Abla6*, Jorge Braier7*, Guido Felizzia7*, Elena Sieni, MD8*, Francesco Pegoraro8*, Cor van den Bos9*, Barbara Degar, MD10, Faisal Razzaqi, MD11*, David Samuel11*, Zdenka Krenova12*, Olga Gryniewicz-Kwiatowska13*, Steven W. Allen14*, Rima Jubran15*, Itziar Astigarraga16*, Maria Kondyli17*, Michael Girschikofsky18*, Carl Friedrich Classen19*, Sheila Weitzman20*, Eli L. Diamond21* and James A. Whitlock20

1Division of Haematology/Oncology, The Hospital for Sick Children/University of Toronto, Toronto, ON, Canada
2Department of Pathology, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA
3Paris-Saclay University, Versailles SQY University, EA4340-BECCOH, Versailles, France
4Assistance Publique–Hôpitaux de Paris (AP-HP), Ambroise-Paré Hospital, Pathology Department, Boulogne, France
5Hospital Nacional de Pediatria Garrahan, Beunos Aires, Argentina
6Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
7Hospital Nacional de Pediatria Garrahan, Buenos Aires, Argentina
8Department of Hematology and Oncology, Meyer Children’s Hospital IRCCS, Florence, Italy
9Department of Hemato-Oncology Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
10Dana Farber Cancer Institute and Boston Children’s Hospital, Boston, MA
11Valley Children’s Hospital, Madera, CA
12Department of Pediatric Oncology, University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic
13Department of Pediatric Oncology, Children’s Memorial Health Institute, Warsaw, Poland
14UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
15Children’s Hospital Los Angeles, Los Angeles, CA
16Department of Pediatrics, Hospital Universitario Cruces, Osakidetza, IIS, Bizkaia, UPV/EHU, Barakaldo, Spain
17CHU Saint-Justine, Montreal, QC, Canada
18Ordensklinikum, Linz Elisabethinen, Austria
19University Children's Hospital, Rostock, Germany
20Division of Haematology/Oncology, The Hospital for Sick Children/University of Toronto, Toronto, Canada
21Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY

Mitali Sen, MD1*, Gordon J Ruan, M.D.2, Samuel B Reynolds, MD, BS3, Haadi Ali, MD3, XI Yang, MD4, Diana Morlote, MD5*, Aishwarya Ravindran, M.B.B.S.6*, Lauren Kelly Shea, MD, MS7, Matthew J Koster, M.D.8*, Jithma P Abeykoon, MD2, Hind Salama, MD9*, Xinxin Cao, MD10*, Asra Z. Ahmed, M.D.11, Ronald S Go, M.D.2 and Gaurav Goyal, MD12

1rheumatology, university of alabama at birmingham, Birmingham, AL
2Division of Hematology, Mayo Clinic, Rochester, MN
3Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
4Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
5University of Alabama at Birmingham, Birmingham, AL
6Department of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL
7O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
8Division of Rheumatology, Mayo Clinic, Rochester, MN
9Divison of Hematology & HSCT, Departement of Oncology, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia
10oncology, Peking union medical college hospital, BEIJING, CHN
11Division of Hematology and Medical Oncology, University of Michigan, Ann Arbor, MI
12Division of Hematology and Medical Oncology, University of Alabama at Birmingham, Birmingham, AL

Sabrina R Wilcox, MD1, XI Yang, MD2, Asra Z. Ahmed, M.D.3,4 and Samuel B Reynolds, MD, BS1

1Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
2Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
3University of Michigan Health System, Ann Arbor, MI
4Division of Hematology and Medical Oncology, University of Michigan, Ann Arbor, MI

Ali Abdelhay, MD1, Basant Eltaher, MD2*, Mouna Reghis, MD3*, Aditya Sanjeevi, MD, MBBS2, Aniket Vijay Rao, MD4* and Peter A. Kouides, MD5

1Department of Internal Medicine, Rochester General Hospital, Rochester, NY
2Rochester General Hospital, Rochester, NY
3Rochester General Hospital, Rochester N.Y, NY
4Internal Medicine, Rochester General Hospital, Rochester, NY
5Department of Hematology, Rochester General Hospital, Rochester, NY

Naval Daver, MD1, Andrew Danquah2*, Didier Halimi2*, Jérôme Wojcik3* and Emmanuel Monnet2*

1MD Anderson Cancer Center, Houston, TX
2Sobi, Basel, Switzerland
3Data2time Sàrl, Froideville, Switzerland

Yi Miao, MD1*, Xuzhang Lu2*, Chunling Wang, PhD3*, Bingzong Li, MD, PhD4, Sun Miao5*, Yun Zhuang6*, Haiwen Ni, MD, PhD7*, Xiaoyan Xie8*, Jingyan Xu, MD9*, Yunping Zhang10*, Min Zhao11*, Min Xu, PhD12*, Wanchuan Zhuang, MD13*, Weiying Gu, PhD14*, Haiying Hua, MD15*, Jianfeng Zhu16*, Maozhong Xu17*, Tao Jia18*, Ping Liu19*, Lijia Zhai20*, Tongtong Zhang21*, Qiurong Shan22*, Qiudan Shen23*, Guoqiang Lin24*, Jun Qian25*, Yuqing Miao26*, Wenyu Shi27* and Jianyong Li, MD28

1Lymphoma Center, Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2Department of Hematology, Affiliated Changzhou Second Hospital of Nanjing Medical University, Changzhou, China
3Department of Hematology, Huai'an First People's Hospital, Huai'an, China
4Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
5Department of Hematology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University,, Jingjiang, China
6Department of Hematology, Wu Xi People's Hospital, Wuxi, China
7The Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, China
8Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China
9Department of Hematology, The Affliated Drum Tower Hospital, Nanjing, China
10The Affiliated Yixing Hospital of Jiangsu University, Yixing, China
11Department of Hematology, Wuhu Second People's Hospital, Wuhu, China
12Zhangjiagang First Affiliated Hospital of Soochow University, Zhangjiagang, China
13The Second People's Hospital of Lianyungang, Lianyungang, China
14Department of Hematology, Changzhou First People's Hospital, Third Affiliated to Soochow University, Changzhou, China
15Affiliated Hospital of Jiangnan University, Jiangsu, CHN
16Department of Hematology, the People's Hospital of Taizhou, Taizhou, China
17The Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, China
18The First People's Hospital of Lianyungang, Lianyungang, China
19The Affiliated Wuxi No.2 People's Hospital of Nanjing Medical University, Wuxi, CHN
20Department of Hematology, Affiliated Hospital of Yangzhou University, Yangzhou, China
21Department of Hematology, Rudong County People's Hospital, Rudong, China
22Department of Hematology, Shuyang Traditional Chinese Medicine Hospital, Shuyang, China
23Department of Hematology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China
24Huai'an Hospital Affiliated to Xuzhou Medical College and Huai'an Second People's Hospital, Huai'an, China
25Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, China., Zhenjiang, China, China
26Department of Hematology, The First People’s Hospital of Yancheng, The Yancheng Clinical College of Xuzhou Medical University, Yancheng, China
27Department of Oncology, Affiliated Hospital of Nantong University, Nantong, China
28First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Andrei Pobischan1*, Alyce Hayes, MBChB, MRCPCH2*, Catriona Lewis3*, Asima Chaudhary, MBBS4*, Anupama Rao5*, Kimberly Gilmour, Ph.D.6*, Jayashree Motwani, MBBS, MRCPath7*, Ben Carpenter, MD8*, Galina Jigoulina9*, Zohreh Nademi, MD, PHD10*, Srividhya Senthil, MBBS11*, Majid Madni12*, Sushil Gunaseelan, MD13*, Beki James, MD14* and Salah Ali, MRCP15*

1Paediatric Haematology and Oncology unit, Leeds Children's Hospital, Leeds, ENG, United Kingdom
2Paediatric Oncology and Haematology, Leeds Children's Hospital, Leeds, United Kingdom
3Leeds Children's Hospital, Leeds, United Kingdom
4Paediatric haematology, Great Ormond Street Hospital, London, United Kingdom
5Department of Hematology, Great Ormond Street Hospital, London, United Kingdom
6Department of Immunology, Great Ormond Street Hospital, London, GBR
7Paediatric haematology and oncology, Birmingham Children's Hospital, Birmingham, United Kingdom
8University College London Hospitals NHS Foundation Trust, London, United Kingdom
9Paediatric haematology and oncology, Southampton CHildren's Hospital, Southampton, United Kingdom
10Department Paediatric Stem Cell Transplant, Great North Children's Hospital, Newcastle Upon Tyne, GBR
11Blood and Marrow Transplant Unit, Royal Manchester Children's Hospital, Manchester, United Kingdom
12Department of paediatric haematology and oncology, Nottingham University Hospitals, Nottingham, United Kingdom
13Paediatric Oncology and Haematology, Sheffield Children's Hospital, Sheffield, United Kingdom
14Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
15Department of paediatrics, Cancer Centre Of Southeastern Ontario, Queens University, kingston, ON, Canada

Dan Yoon, MS1*, Erim Keresteci1*, Bita Jafarzadeh, MD1*, Vahid Mehrtash, MD1*, Hortense Le, MS1,2*, Nicolas Coudray, PhD3*, Aristotelis Tsirigos, PhD1,2,3 and Christopher Y. Park, MD, PhD1,2

1Department of Pathology, New York University School of Medicine, New York, NY
2Department of Medicine, Division of Precision Medicine, New York University School of Medicine, New York, NY
3Applied Bioinformatics Laboratories, New York University School of Medicine, New York, NY

*signifies non-member of ASH